Il car sharing (auto in condivisione) è il sistema più semplice, comodo e conveniente per muoversi liberamente con un'auto, senza doverne essere il proprietario: un innovativo servizio di mobilità sostenibile, che coniuga rispetto per l'ambiente e possibilità di risparmio per il suo utilizzatore.
Con il car sharing, infatti, si acquista solo l'uso di un'auto (anziché l'auto stessa), per il tempo che serve - da una sola ora ad uno o più giorni consecutivi - e per andare ovunque, in città e fuori. E' possibile scegliere ogni volta un'auto diversa, tra i tanti modelli disponibili: i veicoli car sharing hanno moltissimi vantaggi, tra cui libero accesso nella Z.T.L. (Zona a Traffico Limitato), possibilità di percorrere corsie e vie riservate ai mezzi pubblici, sosta gratuita nei parcheggi a pagamento.
Tutto compreso: carburante, bollo e assicurazione!
Il car sharing (auto in condivisione) è il sistema più semplice, comodo e conveniente per muoversi liberamente con un'auto, senza doverne essere il proprietario: un innovativo servizio di mobilità sostenibile, che coniuga rispetto per l'ambiente e possibilità di risparmio per il suo utilizzatore.
Con il car sharing, infatti, si acquista solo l'uso di un'auto (anziché l'auto stessa), per il tempo che serve - da una sola ora ad uno o più giorni consecutivi - e per andare ovunque, in città e fuori. E' possibile scegliere ogni volta un'auto diversa, tra i tanti modelli disponibili: i veicoli car sharing hanno moltissimi vantaggi, tra cui libero accesso nella Z.T.L. (Zona a Traffico Limitato), possibilità di percorrere corsie e vie riservate ai mezzi pubblici, sosta gratuita nei parcheggi a pagamento.
Tutto compreso: carburante, bollo e assicurazione!
Regione che vai, cura che trovi (forse). I principali risultati del XVII Rapporto sulle politiche della cronicità realizzato dal Coordinamento nazionale delle Associazioni dei Malati Cronici di Cittadinanzattiva
I principali dati del Rapporto annuale sulle politiche della cronicità realizzato da Coordinamento nazionale delle Associazioni dei Malati Cronici di Cittadinanzattiva. Presentazione dei principali dati a cura di Maria Teresa Bressi
La presentazione di Tonino Aceti, coordinatore nazionale del Tribunale per i diritti del malato di Cittadinanzattiva e direttore del Coordinamento nazionale delle Associazioni dei Malati Cronici delle principali proposte contenute nella Relazione 2018.
Il car sharing (auto in condivisione) è il sistema più semplice, comodo e conveniente per muoversi liberamente con un'auto, senza doverne essere il proprietario: un innovativo servizio di mobilità sostenibile, che coniuga rispetto per l'ambiente e possibilità di risparmio per il suo utilizzatore.
Con il car sharing, infatti, si acquista solo l'uso di un'auto (anziché l'auto stessa), per il tempo che serve - da una sola ora ad uno o più giorni consecutivi - e per andare ovunque, in città e fuori. E' possibile scegliere ogni volta un'auto diversa, tra i tanti modelli disponibili: i veicoli car sharing hanno moltissimi vantaggi, tra cui libero accesso nella Z.T.L. (Zona a Traffico Limitato), possibilità di percorrere corsie e vie riservate ai mezzi pubblici, sosta gratuita nei parcheggi a pagamento.
Tutto compreso: carburante, bollo e assicurazione!
Il car sharing (auto in condivisione) è il sistema più semplice, comodo e conveniente per muoversi liberamente con un'auto, senza doverne essere il proprietario: un innovativo servizio di mobilità sostenibile, che coniuga rispetto per l'ambiente e possibilità di risparmio per il suo utilizzatore.
Con il car sharing, infatti, si acquista solo l'uso di un'auto (anziché l'auto stessa), per il tempo che serve - da una sola ora ad uno o più giorni consecutivi - e per andare ovunque, in città e fuori. E' possibile scegliere ogni volta un'auto diversa, tra i tanti modelli disponibili: i veicoli car sharing hanno moltissimi vantaggi, tra cui libero accesso nella Z.T.L. (Zona a Traffico Limitato), possibilità di percorrere corsie e vie riservate ai mezzi pubblici, sosta gratuita nei parcheggi a pagamento.
Tutto compreso: carburante, bollo e assicurazione!
Regione che vai, cura che trovi (forse). I principali risultati del XVII Rapporto sulle politiche della cronicità realizzato dal Coordinamento nazionale delle Associazioni dei Malati Cronici di Cittadinanzattiva
I principali dati del Rapporto annuale sulle politiche della cronicità realizzato da Coordinamento nazionale delle Associazioni dei Malati Cronici di Cittadinanzattiva. Presentazione dei principali dati a cura di Maria Teresa Bressi
La presentazione di Tonino Aceti, coordinatore nazionale del Tribunale per i diritti del malato di Cittadinanzattiva e direttore del Coordinamento nazionale delle Associazioni dei Malati Cronici delle principali proposte contenute nella Relazione 2018.
Arnaud Emerieu, President of the European Social Insurance Platform, BelgiumCittadinanzattiva onlus
The document outlines 5 priority areas for payers' perspectives on access to innovation: 1) Steering R&D to public health needs, 2) Ensuring evidence base for innovation through strengthened health technology assessment, 3) Strengthening national pricing and reimbursement mechanisms in interests of patients, payers and society, 4) Increasing transparency around innovative pharmaceuticals, and 5) Supporting innovation in context of sustainable healthcare systems. It advocates for transparent health technology assessment processes, voluntary collaboration between countries on pricing negotiations, ensuring access to medicines based on proven patient benefit, and promoting transparency around clinical trial data and pharmaceutical prices and expenditures to balance innovation and sustainability of health systems.
Sannié, member of the patients' consultative group of the French National Agency for Medicines and Health Product Safety, France, for European Patients' Rights Day 2017
The world's population is growing larger, older, and sicker, placing increasing challenges on healthcare systems to expand access to care with finite resources. Chronic diseases now account for 70% of illnesses, and the population over 50 will increase by over 500 million by 2025. Healthcare systems face constraints like aging populations, growing disease burdens, and limited budgets. However, new medical technologies in development and advances in data analytics provide optimism for healthier futures. Key questions remain around how to introduce high-value innovations and make systems more sustainable.
Alessia Squillace, Tribunal for Patients' Rights - A campaign on acces on inn...Cittadinanzattiva onlus
The Tribunale per i diritti del malato di Cittadinanzattiva promotes citizens' rights in health services in Italy with over 10,000 active citizens working out of 330 locations. New drugs for treating Hepatitis C offer a cure and simplify treatment but elevated prices and eligibility criteria limit access for many patients. The organization established a national tutelage program providing information, counseling, and monitoring access to the new drugs which has helped increase funding and prescription centers, expand eligibility criteria, and start over 53,000 patients on treatment, though access remains limited for some groups.
This document discusses ways to make access to innovative medicines more sustainable in the EU. It suggests the EU take a more comprehensive approach when negotiating medicine prices that considers public and private research contributions, product benefits, healthcare budget and organization impacts, and patent duration. It also recommends compulsory licensing be considered when prices are abnormally high. The role of regulators could be improved by expanding compassionate use programs, aligning regulatory and health technology assessment timelines, and increased post-approval monitoring. The EU should protect solidarity principles, encourage transparency, generalize orphan medicine access mechanisms, and encourage joint procurement to reduce prices.
Gottfried Endel, Main Association of Austrian Social Insurance Institutions, ...Cittadinanzattiva onlus
Gottfried Endel, Main Association of Austrian Social Insurance Institutions, Austria for 2017 European Patients' Rights Day in Brussels, "The payers' perspective on access to innovation"
Pamela Mazzocato discusses how lean practices can be used to improve emergency care by reducing waste and inefficiency. Two case studies are described where lean was used: 1) At Danderyd Hospital, lean reduced the time to surgery for hip fractures from 24.8 to 20 hours and increased the percentage of patients operated on within 24 hours from 47% to 83%. 2) At Karolinska University Hospital, lean reduced non-value adding time and variation, increasing the percentage of patients ready to leave the emergency department within 4 hours by up to 29% and decreasing the waiting time for first physician assessment by up to 56%. Lean focuses on continually improving processes to increase value for patients.
EPRD16 - Eileen Nolan Shortiss - National development of electronic cancer re...Cittadinanzattiva onlus
The National Cancer Control Programme in Ireland developed an electronic cancer referral system to streamline the referral process from GPs to cancer centers. Phase 1 involved online referral forms accessible through Healthlink, the national health messaging system. Phase 2 integrated the forms into accredited GP practice management systems. The project cost €250,000 and overcame obstacles like engaging GPs and vendors. Key success factors included support from hospitals and GPs, and service level agreements defining responsibilities. The system provides automatic receipt confirmation, reduces stress for patients, and lowers DNA rates compared to mailed/faxed referrals.
EPRD16 - Giuseppe Banfi - Use of a software to optimize the surgical processCittadinanzattiva onlus
The document discusses a project at IRCCS Galeazzi orthopaedic hospital in Milan, Italy to implement a software platform to optimize surgical workflow and ensure traceability of procedures. The hospital performs over 14,000 surgeries per year. The project aimed to digitize coordination between operating rooms, wards, and support departments. Results of the project included treating 100% of femur fractures within 48 hours, improved operating room efficiency and utilization, and reduced wait times. The project concluded that innovative technologies can significantly increase productivity, efficiency, patient safety and satisfaction, and optimal use of resources in surgical workflows.
EPRD16 - Cristiana Montani Natalucci - The two faces of health: Between waste...Cittadinanzattiva onlus
The document discusses a project by Cittadinanzattiva that examined waste in the Italian healthcare system from the perspective of citizens. It defined waste as any activity, behavior, good or service that uses resources but does not improve health, wellbeing or quality of life. Citizens reported 104 cases of waste, which were classified into 3 categories: use of equipment and facilities (46%), services and performances (37%), and human resource management (17%). Common types of waste included unused medical equipment, unnecessary bureaucracy, and staff assigned to non-health tasks. Based on its findings, Cittadinanzattiva developed a roadmap of 34 activities to improve sustainability and outcomes in the healthcare system.
EPRD16 - Paul Vincke - European Healthcare fraud and corruption networkCittadinanzattiva onlus
This document discusses healthcare waste and how to reduce it. It defines healthcare waste as spending that can be eliminated without reducing quality of care, estimating it accounts for 30% of total healthcare spending. It breaks down waste into unintended waste at 40% and waste due to integrity violations like fraud at 15%. Patients are exposed to physical and financial harm from both overuse and underuse of low-value care, as well as from informal payments and reimbursement refusals. To reduce waste, the document suggests patients and healthcare professionals must be informed, educated, and made responsible for reducing unnecessary spending.
Arnaud Emerieu, President of the European Social Insurance Platform, BelgiumCittadinanzattiva onlus
The document outlines 5 priority areas for payers' perspectives on access to innovation: 1) Steering R&D to public health needs, 2) Ensuring evidence base for innovation through strengthened health technology assessment, 3) Strengthening national pricing and reimbursement mechanisms in interests of patients, payers and society, 4) Increasing transparency around innovative pharmaceuticals, and 5) Supporting innovation in context of sustainable healthcare systems. It advocates for transparent health technology assessment processes, voluntary collaboration between countries on pricing negotiations, ensuring access to medicines based on proven patient benefit, and promoting transparency around clinical trial data and pharmaceutical prices and expenditures to balance innovation and sustainability of health systems.
Sannié, member of the patients' consultative group of the French National Agency for Medicines and Health Product Safety, France, for European Patients' Rights Day 2017
The world's population is growing larger, older, and sicker, placing increasing challenges on healthcare systems to expand access to care with finite resources. Chronic diseases now account for 70% of illnesses, and the population over 50 will increase by over 500 million by 2025. Healthcare systems face constraints like aging populations, growing disease burdens, and limited budgets. However, new medical technologies in development and advances in data analytics provide optimism for healthier futures. Key questions remain around how to introduce high-value innovations and make systems more sustainable.
Alessia Squillace, Tribunal for Patients' Rights - A campaign on acces on inn...Cittadinanzattiva onlus
The Tribunale per i diritti del malato di Cittadinanzattiva promotes citizens' rights in health services in Italy with over 10,000 active citizens working out of 330 locations. New drugs for treating Hepatitis C offer a cure and simplify treatment but elevated prices and eligibility criteria limit access for many patients. The organization established a national tutelage program providing information, counseling, and monitoring access to the new drugs which has helped increase funding and prescription centers, expand eligibility criteria, and start over 53,000 patients on treatment, though access remains limited for some groups.
This document discusses ways to make access to innovative medicines more sustainable in the EU. It suggests the EU take a more comprehensive approach when negotiating medicine prices that considers public and private research contributions, product benefits, healthcare budget and organization impacts, and patent duration. It also recommends compulsory licensing be considered when prices are abnormally high. The role of regulators could be improved by expanding compassionate use programs, aligning regulatory and health technology assessment timelines, and increased post-approval monitoring. The EU should protect solidarity principles, encourage transparency, generalize orphan medicine access mechanisms, and encourage joint procurement to reduce prices.
Gottfried Endel, Main Association of Austrian Social Insurance Institutions, ...Cittadinanzattiva onlus
Gottfried Endel, Main Association of Austrian Social Insurance Institutions, Austria for 2017 European Patients' Rights Day in Brussels, "The payers' perspective on access to innovation"
Pamela Mazzocato discusses how lean practices can be used to improve emergency care by reducing waste and inefficiency. Two case studies are described where lean was used: 1) At Danderyd Hospital, lean reduced the time to surgery for hip fractures from 24.8 to 20 hours and increased the percentage of patients operated on within 24 hours from 47% to 83%. 2) At Karolinska University Hospital, lean reduced non-value adding time and variation, increasing the percentage of patients ready to leave the emergency department within 4 hours by up to 29% and decreasing the waiting time for first physician assessment by up to 56%. Lean focuses on continually improving processes to increase value for patients.
EPRD16 - Eileen Nolan Shortiss - National development of electronic cancer re...Cittadinanzattiva onlus
The National Cancer Control Programme in Ireland developed an electronic cancer referral system to streamline the referral process from GPs to cancer centers. Phase 1 involved online referral forms accessible through Healthlink, the national health messaging system. Phase 2 integrated the forms into accredited GP practice management systems. The project cost €250,000 and overcame obstacles like engaging GPs and vendors. Key success factors included support from hospitals and GPs, and service level agreements defining responsibilities. The system provides automatic receipt confirmation, reduces stress for patients, and lowers DNA rates compared to mailed/faxed referrals.
EPRD16 - Giuseppe Banfi - Use of a software to optimize the surgical processCittadinanzattiva onlus
The document discusses a project at IRCCS Galeazzi orthopaedic hospital in Milan, Italy to implement a software platform to optimize surgical workflow and ensure traceability of procedures. The hospital performs over 14,000 surgeries per year. The project aimed to digitize coordination between operating rooms, wards, and support departments. Results of the project included treating 100% of femur fractures within 48 hours, improved operating room efficiency and utilization, and reduced wait times. The project concluded that innovative technologies can significantly increase productivity, efficiency, patient safety and satisfaction, and optimal use of resources in surgical workflows.
EPRD16 - Cristiana Montani Natalucci - The two faces of health: Between waste...Cittadinanzattiva onlus
The document discusses a project by Cittadinanzattiva that examined waste in the Italian healthcare system from the perspective of citizens. It defined waste as any activity, behavior, good or service that uses resources but does not improve health, wellbeing or quality of life. Citizens reported 104 cases of waste, which were classified into 3 categories: use of equipment and facilities (46%), services and performances (37%), and human resource management (17%). Common types of waste included unused medical equipment, unnecessary bureaucracy, and staff assigned to non-health tasks. Based on its findings, Cittadinanzattiva developed a roadmap of 34 activities to improve sustainability and outcomes in the healthcare system.
EPRD16 - Paul Vincke - European Healthcare fraud and corruption networkCittadinanzattiva onlus
This document discusses healthcare waste and how to reduce it. It defines healthcare waste as spending that can be eliminated without reducing quality of care, estimating it accounts for 30% of total healthcare spending. It breaks down waste into unintended waste at 40% and waste due to integrity violations like fraud at 15%. Patients are exposed to physical and financial harm from both overuse and underuse of low-value care, as well as from informal payments and reimbursement refusals. To reduce waste, the document suggests patients and healthcare professionals must be informed, educated, and made responsible for reducing unnecessary spending.
21. Considerato il divario digitale ancora in essere, ribadiamo la necessità di
una accelerata sul tema, chiedendo un impegno per sciogliere tutti i nodi
che bloccano la “digitalizzazione” del nostro paese e armonizzare tutto il
processo.
Telecomunicazioni